Monte Rosa Therapeutics, Inc.GLUENASDAQ
Loading
Operating cash flow minus capital expenditures
Latest
$-27.50M
↑ 26% vs avg
Percentile
P50
Within normal range
Streak
1 yr
Consecutive declineContracting
Average
$-37.26M
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | $-27.50M | -172.3% |
| 2024 | $38.01M | +160.5% |
| 2023 | $-62.84M | +40.4% |
| 2022 | $-105.38M | -52.5% |
| 2021 | $-69.09M | -161.3% |
| 2020 | $-26.44M | -249.9% |
| 2019 | $-7.56M | - |